1/ It was good to see @POTUS address the mental health epidemic in his #SOTU . But if we want any chance at meeting this huge and growing need, we need accessible and scalable solutions that don’t discriminate on race or socioeconomic status.
2/ In addition to conventional treatments like therapy, we need treatments that target underlying conditions, not just symptomatology. Major advances in digital therapeutics make this possible and without the serious side effects of many prescription drugs.
3/ As I’ve said before, if software can have damaging effects on our brain chemistry, why can’t it also help us reverse them? Digital therapeutics can be a breakthrough part of this solution.
4/ Disclaimer: I'm helping take @AkiliLabs public to address cognitive health in a novel way. They’ve developed the first FDA-cleared prescription digital therapeutic for pediatric ADHD. If you’re a parent, ask your doctor for more info.
5/ Akili is currently cleared to treat ADHD, but they are already testing their patented technology to treat other cognitive conditions like depression, autism, and MS. bit.ly/dnaa-info
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1/ Ahead of #SOTU2022 I want to reiterate what I’ve said for years: Energy independence has and will continue to be one of America's most critical vulnerabilities. A real and urgent national security issue.
2/ In less than a week, we’ve seen WTI/crude >$100/barrel, gas >$5/gallon in CA, and a natural gas crisis emerging in Europe. Post-Gulf War, we invested in medium-term solutions like domestic shale. This was a good stop-gap but not a long-term solution.
3/ Hands down the fastest and most realistic solution is solar. We need to deploy solar across the country and accelerate the mass transition to clean energy NOW.
1/ Climate change is one of the most important existential threats of our generation. America’s utilities infrastructure is woefully unprepared to meet our energy needs.
That’s why @PalmettoEnergy is the biggest investment I’ve made to date.
2/ Outages, rolling blackouts, operational failures, wildfires, hurricanes – our utilities face an uphill battle when they’re already saddled with massive debt and multi-decade old equipment. All this, and energy prices are still rising.
3/ Palmetto wants to do to the fossil fuel industry what the cell phone did to the telecom industry. Fundamentally change the economics and make clean energy affordable and available to everyone.
1/ Last year, we launched @SocialCapital Emerging Managers, a program designed for investment professionals looking to accelerate their careers without the typical years of waiting it takes to be allocated your own portfolio at traditional funds.
2/ We hired 11 managers, initially staking them with $4M each. They managed their own books, while also working on investments and other projects. After reviewing year-end performance, we have allocated additional capital for year 2 of the cohort.
3/ We’re excited to invite folks to apply for the EM Class of 2022. As an EM, you have access to three key benefits: (1) capital commitment of 3 years; (2) the platform/infrastructure required to trade; (3) ability to own your track record outright.
1/ As a parent, I often wonder whether there is a way for technology to be part of the solution to our country’s growing concerns around mental health.
2/ @AkiliLabs is creating a new class of medicine. Their first product is a first-of-its-kind FDA-cleared prescription video game to treat pediatric ADHD in 8-12 year-olds.
3/ Their technology targets the fronto-parietal attention control networks of the brain to improve attention function (e.g., focus, multitasking).
1/ Chronic kidney disease (CKD) is one of the most prevalent medical conditions, affecting more than 1 in 7 U.S. adults (as well as my late father). We spend up to $500B/yr to treat CKD with drugs and dialysis, which may incrementally slow down the disease but not reverse it
2/ Today we partnered with ProKidney, which is changing how we treat CKD. Their clinical data shows its treatment can not only significantly slow the onset of CKD compared to existing therapies, but even REVERSE the loss of kidney function, a first for CKD patients
3/ By taking ProKidney public, they will have the capital to continue Phase 3 clinical trials which have already commenced this month. We are excited to work with a company that has the opportunity to change how millions of people worldwide cope with this terrible disease
1/ $CLOV - upgraded MA PPO rating of 3.5 Stars (vs prior 3.0 Stars) - Proud of the @CloverHealth team and excited to see what the future holds 💪
2/ Shows CLOVs ability to execute and validates their wide-open network approach to access a larger TAM compared with narrow-network plans offered by competitors
3/ Around 50% of $CLOV's membership who self-identify are those of minority background vs only 34% average for the industry